Ammar 2013.
Methods | Parallel randomised control trial |
Participants | Location: Ain Shams Maternity Hospital, Egypt Eligibility: women scheduled to undergo elective caesarean section at or after 37 completed weeks (based on the last menstrual period) Exclusion criteria: women with obstetric complications (including pre‐eclampsia, antepartum haemorrhage, fetal anomaly, hypertensive disease), chronic disease (including diabetes mellitus and renal disease) or preoperative infection were excluded. |
Interventions | Intervention: 2 doses of 12 mg dexamethasone administered intramuscularly 12 hours apart, 48 hours before delivery (n = 300) Control: usual care (without antenatal corticosteroids) (n = 300) |
Outcomes |
|
Notes | Study dates: March 2010 to March 2011 Funding sources: not reported Declarations of interest: "There is no relationship for any author that may influence the objectivity of the paper." We emailed the trial authors on 7 February 2021 to ask for information regarding prospective trial registration, randomisation and number of women lost to follow‐up. Awaiting reply. Not included in 2021 update because of lack of response from trial authors regarding our trustworthiness criteria (trial published since 2010 without prospective registration) |